Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine · 29.06.2023 · 388 (26) · 2444-2455
DOI: 10.1056/nejmoa2207940 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 29.06.2023. Verfasst von Geert D'Haens und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (G.D.); Dr. Henry D. Janowitz Division of Gas…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 377-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (G.D.); Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York (M.D.…
ORCID-Profile: Bruce E Sands
Förderung
- Eli Lilly and Company
Zitieren
APA
D'Haens, G., Dubinsky, M., Kobayashi, T., Irving, P. M., Howaldt, S., Pokrotnieks, J., Krueger, K., Laskowski, J., Li, X., Lissoos, T., Milata, J., Morris, N., Arora, V., Milch, C., Sandborn, W., Sands, B. E., & LUCENT Study Group (2023). Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine, 388(26), 2444-2455. https://doi.org/10.1056/nejmoa2207940
Vancouver
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, et al. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine. 2023;388(26):2444-2455. doi:10.1056/nejmoa2207940
BibTeX
@article{DHaens2023,
author = {D'Haens, Geert and Dubinsky, Marla and Kobayashi, Taku and Irving, Peter M and Howaldt, Stefanie and Pokrotnieks, Juris and Krueger, Kathryn and Laskowski, Janelle and Li, Xingyuan and Lissoos, Trevor and Milata, Joe and Morris, Nathan and Arora, Vipin and Milch, Catherine and Sandborn, William and Sands, Bruce E and LUCENT Study Group, LUCENT Study Group},
title = {Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {26},
pages = {2444--2455},
doi = {10.1056/nejmoa2207940}
}
EUVIMED